Search results
Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy
Medical Xpress· 3 hours agoIn an editorial, in Oncoscience titled "Therapeutic opportunities for hypermutated urothelial ...
Merus Carcinoma Treatment Awarded US FDA's Breakthrough Therapy Designation
Morningstar· 6 hours agoBy Dean Seal Merus said federal regulators have granted breakthrough therapy designation to its carcinoma treatment petosemtamab. The clinical-stage oncology company said ...
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 9 hours agoOpdivo is a programmed death-1 (PD-1) immune checkpoint inhibitor. It has been approved to treat a...
Springfield doctor shares tips on how to prevent skin cancer for Skin Cancer Awareness Month
KY3 Springfield· 9 hours agoMay is Skin Cancer Awareness Month, and it’s a good time to remember what to look for and how to...
10 Stars You Won't Believe Are 70: Christie Brinkley, John Travolta and More
OK! Magazine· 7 hours agoBorn on May 24, 1953, Alfred Molina looks younger than his age. At 70, he has already starred in...
Pipeline Moves: Phase III completion for Corcept’s relaorilant
Clinical Trials Arena via Yahoo Finance· 11 hours agoMeanwhile, Regeneron has completed a Phase II trial of its candidate mibavademab in lipodystrophy...
Woman Learns She’s Expecting 'Perfect' Rainbow Baby, Then Finds Out She Has Breast Cancer...
People Magazine· 1 day agoTiffany Gagliardi was diagnosed with invasive ductal carcinoma, a form of breast cancer, while...
Leads Biolabs is Proud to Announce its Participation in the 2024 ASCO Annual Meeting with One Oral...
WPRI Providence· 15 hours agoThe 2024 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago from May 31 to June 4, 2024. Leads Biolabs will present the exciting clinical data on its four innovative clinical programs at the ASCO meeting.
Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2024 Results: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 6 hours agoThese developments are likely to enhance the product's market penetration and usage. Furthermore,...
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side...
Quartz· 3 hours agoMerck announced Monday that it is pulling the plug on its phase 3 trial of an experimental...